What happens if unproven stem cell clinic firms like GIOSTAR start getting okays from the FDA to do clinical trials? On the one hand, it could reflect a positive trend of stem cell clinic firms working with the FDA and toward compliance. Having more robust data. However, I worry about some of these types of […]
The post Weekly reads: GIOSTAR stem cell clinic IND, cadaver marrow, NIH under Trump 2.0, tweets from a stem cell appeared first on The Niche.